Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/23/2025 | Q3 | -- | $47.6M | $2.19 | -- | -- |
| 07/24/2025 | Q2 | -- | $47.3M | $2.37 | -- | -- |
| 04/24/2025 | Q1 | -- | $43.6M | $1.66 | -- | -- |
| 01/28/2025 | Q4 | -- | $43.4M | $1.87 | -- | -- |
| 10/29/2024 | Q3 | -- | $44.9M | $1.65 | -- | -- |
| 07/24/2024 | Q2 | -- | $41.6M | $1.50 | -- | -- |
| 04/19/2024 | Q1 | -- | $40.2M | $1.01 | -- | -- |
| 01/24/2024 | Q4 | -- | $40.8M | $1.50 | -- | -- |
| 10/26/2023 | Q3 | -- | $37.7M | $1.71 | -- | -- |
| 07/26/2023 | Q2 | -- | $38.5M | $1.84 | -- | -- |
| 04/26/2023 | Q1 | -- | $36.7M | $1.86 | -- | -- |
| 01/24/2023 | Q4 | -- | $36.6M | $2.97 | -- | -- |
| 10/27/2022 | Q3 | -- | $33M | $1.85 | -- | -- |
| 07/21/2022 | Q2 | -- | $31.6M | $1.91 | -- | -- |
| 04/21/2022 | Q1 | -- | $29.7M | $1.59 | -- | -- |
| 01/25/2022 | Q4 | -- | $32.8M | $1.67 | -- | -- |
| 10/21/2021 | Q3 | -- | $35.6M | $2.16 | -- | -- |
| 07/22/2021 | Q2 | -- | $37M | $2.19 | -- | -- |
| 05/04/2021 | Q1 | -- | $37.4M | $1.92 | -- | -- |
| 01/27/2021 | Q4 | -- | $44.6M | $2.19 | -- | -- |
| 10/27/2020 | Q3 | -- | $38.6M | $1.86 | -- | -- |
| 07/23/2020 | Q2 | -- | $33.4M | $1.03 | -- | -- |
| 04/23/2020 | Q1 | -- | $32.5M | $0.98 | -- | -- |
| 01/24/2020 | Q4 | -- | $32.3M | $1.27 | -- | -- |
| 10/24/2019 | Q3 | -- | $33.3M | $1.42 | -- | -- |
| 07/23/2019 | Q2 | -- | $33.5M | $1.69 | -- | -- |
| 04/23/2019 | Q1 | -- | $31M | $1.08 | -- | -- |
| 01/24/2019 | Q4 | -- | $28.9M | $1.13 | -- | -- |
| 10/25/2018 | Q3 | -- | $31.3M | $1.46 | -- | -- |
| 07/24/2018 | Q2 | -- | $30.9M | $1.45 | -- | -- |
| 04/17/2018 | Q1 | -- | $30.1M | $1.11 | -- | -- |
| 01/25/2018 | Q4 | -- | $29.1M | -$0.95 | -- | -- |
| 10/26/2017 | Q3 | -- | $30.4M | $0.87 | -- | -- |
| 07/27/2017 | Q2 | -- | $30.7M | $1.19 | -- | -- |
| 04/25/2017 | Q1 | -- | $29.1M | $0.78 | -- | -- |
| 01/26/2017 | Q4 | -- | $28.5M | $0.91 | -- | -- |
| 10/25/2016 | Q3 | -- | $29.4M | $0.92 | -- | -- |
| 07/26/2016 | Q2 | -- | $28.5M | $1.36 | -- | -- |
| 04/26/2016 | Q1 | -- | $27.1M | $0.72 | -- | -- |
| 01/28/2016 | Q4 | -- | $27.4M | $0.68 | -- | -- |
C&F Financial Corp. reported $47.6M worth of top line sales in its most recent quarter.
C&F Financial Corp. announced earnings per share of $2.19 which represents a beat of analyst forecast a -- per share.
C&F Financial Corp. reported -- that represents -- per share over the last quarter.
C&F Financial Corp.'s earnings are forecast to grow from $6.01 per share to -- per share next year representing an increase of --.
C&F Financial Corp.'s next earnings date is January 28, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.